These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22127975)

  • 1. A diverted total synthesis of mycolactone analogues: an insight into Buruli ulcer toxins.
    Chany AC; Casarotto V; Schmitt M; Tarnus C; Guenin-Macé L; Demangel C; Mirguet O; Eustache J; Blanchard N
    Chemistry; 2011 Dec; 17(51):14413-9. PubMed ID: 22127975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure of two new mycolactones isolated from M. ulcerans subsp. shinshuense.
    Hande SM; Kazumi Y; Lai WG; Jackson KL; Maeda S; Kishi Y
    Org Lett; 2012 Sep; 14(17):4618-21. PubMed ID: 22924773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ring-closing metathesis (RCM)-based approach to mycolactones A/B.
    Gersbach P; Jantsch A; Feyen F; Scherr N; Dangy JP; Pluschke G; Altmann KH
    Chemistry; 2011 Nov; 17(46):13017-31. PubMed ID: 21971832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic variants of mycolactone bind and activate Wiskott-Aldrich syndrome proteins.
    Chany AC; Veyron-Churlet R; Tresse C; Mayau V; Casarotto V; Le Chevalier F; Guenin-Macé L; Demangel C; Blanchard N
    J Med Chem; 2014 Sep; 57(17):7382-95. PubMed ID: 25158122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.
    Mve-Obiang A; Lee RE; Portaels F; Small PL
    Infect Immun; 2003 Feb; 71(2):774-83. PubMed ID: 12540557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycolactone activation of Wiskott-Aldrich syndrome proteins underpins Buruli ulcer formation.
    Guenin-Macé L; Veyron-Churlet R; Thoulouze MI; Romet-Lemonne G; Hong H; Leadlay PF; Danckaert A; Ruf MT; Mostowy S; Zurzolo C; Bousso P; Chrétien F; Carlier MF; Demangel C
    J Clin Invest; 2013 Apr; 123(4):1501-12. PubMed ID: 23549080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones.
    Cadapan LD; Arslanian RL; Carney JR; Zavala SM; Small PL; Licari P
    FEMS Microbiol Lett; 2001 Dec; 205(2):385-9. PubMed ID: 11750832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Macrolide Toxin Mycolactone Promotes Bim-Dependent Apoptosis in Buruli Ulcer through Inhibition of mTOR.
    Bieri R; Scherr N; Ruf MT; Dangy JP; Gersbach P; Gehringer M; Altmann KH; Pluschke G
    ACS Chem Biol; 2017 May; 12(5):1297-1307. PubMed ID: 28294596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buruli ulcer.
    Einarsdottir T; Huygen K
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J; Ishii N; Goto M
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb; 80(1):5-10. PubMed ID: 21404590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited repair and structural damages displayed by skeletal muscles loaded with mycolactone.
    Houngbédji GM; Côté CH; Small PL; Frenette J
    Microbes Infect; 2009 Feb; 11(2):238-44. PubMed ID: 19114122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.
    En J; Goto M; Nakanaga K; Higashi M; Ishii N; Saito H; Yonezawa S; Hamada H; Small PL
    Infect Immun; 2008 May; 76(5):2002-7. PubMed ID: 18316387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced Synthesis of Mycolactone Restores the Pathogenesis of
    Strong E; Hart B; Wang J; Orozco MG; Lee S
    Front Immunol; 2022; 13():750643. PubMed ID: 35401531
    [No Abstract]   [Full Text] [Related]  

  • 20. Membrane perturbing properties of toxin mycolactone from Mycobacterium ulcerans.
    López CA; Unkefer CJ; Swanson BI; Swanson JMJ; Gnanakaran S
    PLoS Comput Biol; 2018 Feb; 14(2):e1005972. PubMed ID: 29401455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.